Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

2-hydroxypropyl-β-cyclodextrin

EU orphan designation number: EU/3/13/1124   
Active ingredient: 2-hydroxypropyl-β-cyclodextrin
Indication: Treatment of Niemann-Pick disease, type C
Sponsor: Vtesse Europe Limited
Festival House, 39 Oxford Street, Newbury, Berkshire RG14 1JG, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2013 Orphan designation EMA/OD/191/12 (2013)2561 of 26/04/2013
04/02/2015 Transfer of orphan designation EMA/OD/191/12/T/01 (2015)640 of 02/02/2015